154 related articles for article (PubMed ID: 2465953)
1. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
2. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
3. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
4. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
Yamamoto K; Sekiguchi E; Takatani O
Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
[TBL] [Abstract][Full Text] [Related]
6. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
7. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
9. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
Cortelazzo S; Barbui T; Bassan R; Dini E
Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
[TBL] [Abstract][Full Text] [Related]
10. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
11. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
12. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
13. [Megakaryocytic myelosis--clinical aspects, morphology and platelet function].
Hochhaus A; Höche D; Mindner K; Ostermann G; Meyer M
Klin Wochenschr; 1989 Jan; 67(2):51-9. PubMed ID: 2921844
[TBL] [Abstract][Full Text] [Related]
14. Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders.
Cortelazzo S; Galli M; Castagna D; Viero P; de Gaetano G; Barbui T
Thromb Haemost; 1988 Feb; 59(1):73-6. PubMed ID: 3129810
[TBL] [Abstract][Full Text] [Related]
15. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
[TBL] [Abstract][Full Text] [Related]
16. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
Walsh PN; Murphy S; Barry WE
Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
[TBL] [Abstract][Full Text] [Related]
17. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
Culebras Poza JM; Launay JM; Briere J; Dreux C
Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
[TBL] [Abstract][Full Text] [Related]
18. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytosis: age dependent aetiology and analysis of platelet indices for differential diagnosis.
Syed NN; Usman M; Khurshid M
Indian J Pathol Microbiol; 2007 Jul; 50(3):628-33. PubMed ID: 17883167
[TBL] [Abstract][Full Text] [Related]
20. Platelet abnormalities in myeloproliferative disorders.
Holme S; Murphy S
Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]